Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

PetMed Express Inc

Healthcare US PETS

1.63USD
-0.07(4.12%)

Last update at 2026-06-09T15:37:00Z

Day Range

1.631.72
LowHigh

52 Week Range

3.9215.47
LowHigh

Fundamentals

  • Previous Close 1.70
  • Market Cap88.40M
  • Volume90961
  • P/E Ratio-
  • Dividend Yield21.84%
  • EBITDA4.33M
  • Revenue TTM276.97M
  • Revenue Per Share TTM13.60
  • Gross Profit TTM 78.08M
  • Diluted EPS TTM-0.37

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax 1.58M 27.07M 39.22M 33.89M 49.12M
Minority interest - - - - -
Net income 0.23M 21.10M 30.60M 25.85M 37.74M
Selling general administrative 49.47M 30.83M 28.29M 25.26M 24.77M
Selling and marketing expenses 19.42M 18.80M 21.64M 22.75M 22.15M
Gross profit 71.01M 78.08M 89.95M 81.25M 95.31M
Reconciled depreciation 3.55M 2.74M 2.43M 2.26M 2.23M
Ebit -1.43000M 25.71M 37.59M 30.98M 46.17M
Ebitda 2.12M 28.45M 40.01M 33.23M 48.40M
Depreciation and amortization 3.55M 2.74M 2.43M 2.26M 2.23M
Non operating income net other 3.01M 1.36M 1.63M 2.92M 2.95M
Operating income -1.43000M 25.71M 37.59M 30.98M 46.17M
Other operating expenses 258.29M 247.71M 271.63M 253.15M 237.25M
Interest expense 3.01M 0.34M 1.63M 2.92M 2.95M
Tax provision 1.35M 5.97M 8.61M 8.04M 11.38M
Interest income 2.07M 0.34M 0.31M 1.75M 1.86M
Net interest income 2.07M 0.34M 0.31M 1.75M 1.86M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.35M 5.97M 8.61M 8.04M 11.38M
Total revenue 256.86M 273.42M 309.21M 284.12M 283.42M
Total operating expenses 72.44M 52.37M 52.36M 50.27M 49.14M
Cost of revenue 185.84M 195.34M 219.27M 202.88M 188.10M
Total other income expense net 3.01M 1.36M 1.63M 2.92M 1.08M
Discontinued operations - - - - -
Net income from continuing ops 0.23M 21.10M 30.60M 25.85M 37.74M
Net income applicable to common shares 0.23M 21.10M 30.60M 25.85M 37.74M
Preferred stock and other adjustments - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 164.12M 176.32M 187.50M 155.32M 154.43M
Intangible assets 5.86M 0.86M 0.86M 0.86M 0.86M
Earning assets - - - - -
Other current assets 4.72M 5.55M 4.50M 3.53M 1.41M
Total liab 40.32M 34.13M 46.22M 25.31M 19.75M
Total stockholder equity 123.80M 142.19M 141.28M 130.01M 134.68M
Deferred long term liab - - - 0.97M 1.12M
Other current liab 11.29M 5.70M 5.39M 4.68M 2.35M
Common stock 0.02M 0.02M 0.02M 0.02M 0.02M
Capital stock 0.03M 0.03M 0.03M 0.03M 0.03M
Retained earnings 105.49M 130.50M 134.14M 126.18M 122.17M
Other liab - 0.94M 1.28M 0.97M 1.12M
Good will - - - 0.86M 0.86M
Other assets - - - - -
Cash 104.09M 111.08M 118.72M 103.76M 100.53M
Cash and equivalents - - - - -
Total current liabilities 36.50M 33.20M 44.94M 24.34M 18.63M
Current deferred revenue - - - - -
Net debt -104.08600M -111.08000M -118.71800M -103.76200M -100.52900M
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity 18.28M 11.66M 7.11M 3.80M 20.88M
Property plant equipment 26.18M 24.46M 25.45M 25.45M 27.14M
Total current assets 131.45M 151.00M 161.19M 129.02M 126.43M
Long term investments - - - - -
Net tangible assets 123.79M 141.32M 141.27M 130.00M 134.67M
Short term investments - - - - -
Net receivables 1.74M 1.91M 2.59M 3.84M 2.54M
Long term debt - - - - -
Inventory 19.02M 32.45M 34.42M 17.88M 21.37M
Accounts payable 25.21M 27.50M 39.55M 19.66M 16.27M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - -10.32800M -10.65400M -8.39700M
Additional paid in capital - - - - -
Common stock total equity 0.02M 0.02M 0.02M 0.02M 0.02M
Preferred stock total equity 0.00900M 0.00900M 0.00900M 0.00900M 0.00900M
Retained earnings total equity 105.49M 130.50M 134.14M 126.18M 122.17M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 6.49M 0.86M 0.86M 0.86M 0.86M
Deferred long term asset charges - - - - -
Non current assets total 32.67M 25.32M 26.31M 26.30M 28.00M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -10.26000M -1.75200M -2.43200M -2.31100M -0.62000M
Change to liabilities 6.42M -12.04800M 20.64M 5.67M 0.55M
Total cashflows from investing activities -10.26000M -1.75200M -2.43200M -2.31100M -0.62000M
Net borrowings - - - - -
Total cash from financing activities -24.53700M -24.38400M -22.68700M -33.30000M -21.92500M
Change to operating activities - -0.41300M 0.25M 1.44M -0.97300M
Net income 0.23M 21.10M 30.60M 25.85M 37.74M
Change in cash -6.99400M -7.63800M 14.96M 3.23M 22.59M
Begin period cash flow 111.08M 118.72M 103.76M 100.53M 77.94M
End period cash flow 104.09M 111.08M 118.72M 103.76M 100.53M
Total cash from operating activities 27.80M 18.50M 40.08M 38.84M 45.14M
Issuance of capital stock - - - - -
Depreciation 3.55M 2.74M 2.43M 2.26M 2.23M
Other cashflows from investing activities - - - - -
Dividends paid 24.54M 24.38M 22.69M 21.80M 21.93M
Change to inventory 13.43M 1.97M -16.53600M 3.49M 1.97M
Change to account receivables -0.04100M 0.51M 1.13M -1.49200M -0.33500M
Sale purchase of stock - 0.00000M 0.00000M -11.49700M -
Other cashflows from financing activities -10.26000M -1.75200M -2.43200M -2.31100M -0.62000M
Change to netincome 5.27M 4.37M 3.75M 2.86M 3.31M
Capital expenditures 5.26M 1.75M 2.43M 2.31M 0.62M
Change receivables -0.04100M 0.51M 1.13M -1.49200M -0.33500M
Cash flows other operating -1.05500M -0.08500M -1.93300M 0.21M -0.32000M
Exchange rate changes - - - - -
Cash and cash equivalents changes -6.99400M -7.63800M 14.96M 3.23M 22.59M
Change in working capital 18.76M -9.70900M 3.30M 7.87M 1.87M
Stock based compensation 6.62M 4.55M 3.31M 2.82M 3.10M
Other non cash items 0.21M 0.17M 0.13M 0.19M 0.09M
Free cash flow 22.54M 16.75M 37.64M 36.53M 44.52M

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PETS
PetMed Express Inc		 -0.07 4.12% 1.63 - 17.92 0.33 0.78 0.14 -7.1347
ALBHF
Alibaba Health Information Technology Limited		 - -% 0.46 36.00 19.01 0.36 3.63 1.73 25.72
RADLY
Raia Drogasil SA ADR		 -0.03 0.87% 3.41 47.15 32.68 0.34 9.83 0.35 3.29
ALBBY
Alibaba Health Information Technology Limited		 -0.22 2.37% 9.05 34.43 19.84 0.29 3.79 1.73 25.72
SHPPF
Shop Apotheke Europe N.V		 - -% 45.18 - - 2.80 2.28 1.70 78.78

Reports Covered

Stock Research & News

View All

Profile

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express Inc

420 South Congress Avenue, Delray Beach, FL, United States, 33445

Key Executives

Name Title Year Born
Mr. Matthew N. Hulett CEO, Pres & Director 1971
Mr. Bruce S. Rosenbloom Treasurer 1969
Ms. Christine Chambers CFO, Principal Financial Officer & Principal Accounting Officer 1977
Mr. Mark Moseley Chief Technology & Information Officer NA
Mr. Daniel Job Pingree Chief Marketing Officer NA
Ms. Jacqueline Smith VP of People NA
Wendy Zalai Corp. Controller & Corp. Sec. NA
Mr. Mathew N. Hulett CEO, President & Director 1971
Ms. Christine Chambers CFO, Principal Financial Officer, Principal Accounting Officer, Treasurer & Secretary 1978
Ms. Jacqueline Smith Vice President of People NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.